BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6332617)

  • 1. Immunosuppression by cytostatic drugs?
    Ulrichs K; Yu MY; Duncker D; Müller-Ruchholtz W
    Behring Inst Mitt; 1984 May; (74):239-49. PubMed ID: 6332617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An experimental model comparing the antineoplastic and the immunosuppressive effects of some cytostatics.
    Ghyka G; Haraga L
    Arch Roum Pathol Exp Microbiol; 1989; 48(1):33-45. PubMed ID: 2802968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Action of certain antimitotic and immunosuppressive drugs on the electrophoretic mobility of human lymphocytes. Comparison with their action on blood platelets and red cells].
    Larcan A; Stoltz JF; Puchelle JC; Streiff F
    Biomedicine; 1974 Sep; 20(5):352-7. PubMed ID: 4141631
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vitro and in vivo experiments on the immunosuppressive properties of cytostatic substances (author's transl)].
    Schuppli R
    Dermatologica; 1976; 152(5):289-94. PubMed ID: 955228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement and inhibition of mammary tumor formation and growth by cytostatic drugs.
    Medina D; Shepherd F
    Cancer Res; 1977 Oct; 37(10):3571-7. PubMed ID: 908008
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody plaque reduction in vitro and in vivo: a rapid assay for immunosuppressive agents.
    Gavin J; Waterbury W; Freidman H
    Transplant Proc; 1969 Mar; 1(1):413-5. PubMed ID: 4944252
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinogenic effects of cytostatic protocols in CBA/Ca mice.
    Ember I; Raposa T; Varga C; Herceg L; Kiss I
    In Vivo; 1995; 9(1):65-9. PubMed ID: 7545447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of some cytostatic drugs on semiconservative DNA-synthesis and DNA-repair in normal and cancer cells (author's transl)].
    Klein W; Kocsis F; Altmann H
    Arzneimittelforschung; 1975 Oct; 25(10):1623-28. PubMed ID: 1243050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of antitumor effect of cyclophosphamide by centrophenoxine.
    Kanzawa F; Hoshi A; Kuretani K
    Gan; 1971 Jun; 62(3):235-6. PubMed ID: 4398065
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor agents on the production of primary and secondary spleen hemolysin plaque-forming cells.
    Uyeki EM; Long J
    J Pharmacol Exp Ther; 1967 Nov; 158(2):365-71. PubMed ID: 6065156
    [No Abstract]   [Full Text] [Related]  

  • 11. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Change of immunologic reactivity of the animal body under the effect of various antiblastic agents during primary immune response].
    Matveev AB
    Farmakol Toksikol; 1976; 39(3):347-51. PubMed ID: 799970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activity of CP-17,193 and five established immunosuppressives toward the antigens SRBC and EL4.
    Otterness IG
    Clin Exp Immunol; 1981 Nov; 46(2):332-9. PubMed ID: 7039885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of a moderate staphylococcal phage by means of antineoplastic agents].
    Smolianskaia AZ; Leĭkina FI
    Antibiotiki; 1970 Jun; 15(6):514-9. PubMed ID: 4195833
    [No Abstract]   [Full Text] [Related]  

  • 15. Classification of cancer chemotherapeutic drugs according to their ability to potentiate contact sensitivity to dinitrofluorobenzene.
    Ben-Efraim S; Gal T; Zimber C; Weiss DW
    Anticancer Res; 1986; 6(6):1341-5. PubMed ID: 3492958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The cytogenetic effects of antitumor preparations with different mechanisms of action].
    Khlusova MIu; Novitskiĭ VV; Gol'dberg ED
    Eksp Klin Farmakol; 1992; 55(2):49-52. PubMed ID: 1422456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.
    Kolfschoten GM; Pinedo HM; Scheffer PG; Schlüper HM; Erkelens CA; Boven E
    Gynecol Oncol; 2000 Mar; 76(3):362-8. PubMed ID: 10684711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic aspects of cancer chemotherapy.
    Haskell CM
    Annu Rev Pharmacol Toxicol; 1977; 17():179-95. PubMed ID: 326163
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of cytostatic drugs on transplanted tumours. An investigation of the correlation between in vivo and in vitro results.
    Volm M; Mattern J; Wayss K
    Arch Geschwulstforsch; 1974; 43(2):137-44. PubMed ID: 4854798
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of antineoplastic agents on gamma-interferon production in human peripheral blood mononuclear cells.
    Cesario TC; Slater LM; Kaplan HS; Gupta S; Gorse GJ
    Cancer Res; 1984 Nov; 44(11):4962-6. PubMed ID: 6435860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.